{
  "abstract": "One in five young adults in the UK already has fatty-liver disease. In the Avon Longitudinal Study of Parents and Children (ALSPAC), hepatic steatosis was detected in 20.7% of participants at age 24, compared with 2.5% at age 17, an eight-fold increase over 6 years. 1 2 Roughly 1 in 40 showed evidence of fibrosis.2 Cohort data from Sweden demonstrate that individuals diagnosed with non-alcoholic fatty liver disease (NAFLD) before age 25 have markedly higher all-cause and liver-related mortality than matched controls.3",
  "authors": [
    {
      "affiliations": [
        "Gastroenterology and Hepatology, Singapore General Hospital, Singapore",
        "Narratives in Medicine, SingHealth Duke -NUS Medical Humanities Institute, Singapore"
      ],
      "name": "Victoria Sze Min Ekstrom"
    }
  ],
  "title": "Young adults with metabolic dysfunction-associated steatotic liver disease (MASLD): why current services fail – and how we can fix them",
  "uid": "41c45118-026e-56e0-9b7d-11ed27a7f506"
}